Involving patients and the public in all stages of research is becoming increasingly important in order to secure research funding, with many funders even making involvement a condition of funding. More importantly, involving patients and the public in research can make the design stronger, and ensure greater impact from your research.
As part of the Research and Knowledge Exchange Development Framework, RKEO are holding a session on Applying for funding from NIHR – Patient and Public Involvement (PPI). At this session, you’ll he
ar from a Research Fellow / former PPI Senior Programme Manager at the NIHR about what is meant by PPI, and to understand how this can be applied to your research. You’ll also hear from the RDS South West PPI Lead on the importance of involving the public and patients in research.
If you’d like to understand more about what PPI is, and how it can improve your research then come along to this introductory session.
Date: Tuesday 17th October 2017
Time: 09:30-11:30
Venue: Lansdowne Campus
Book your space via the RKE Development Framework page for this event.
For further information, please contact Lisa Gale-Andrews, RKEO Research Facilitator.
Applying for funding from NIHR – Patient and Public Involvement Session 5th April 2017
Supporting patient and public involvement in research










Celebrate World Wellbeing Week This June
Official book launch at Bournemouth University
Take a Break: Join the Creative Wellbeing Event
Psychology, Psychiatry and Neuroscience academics – would you like to get more involved in preparing our next REF submission?
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease